IGFBP-5 Promotes Fibrosis via Increasing Its Own Expression and That of Other Pro-fibrotic Mediators

Pulmonary fibrosis is a hallmark of diseases such as systemic sclerosis (SSc, scleroderma) and idiopathic pulmonary fibrosis (IPF). To date, the therapeutic options for patients with pulmonary fibrosis are limited, and organ transplantation remains the most effective option. Insulin-like growth fact...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Endocrinol (Lausanne)
Huvudupphovsmän: Nguyen, Xinh-Xinh, Muhammad, Lutfiyya, Nietert, Paul J., Feghali-Bostwick, Carol
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2018
Ämnen:
Endocrinology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6196226/
https://ncbi.nlm.nih.gov/pubmed/30374330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00601
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk